Facebook Twitter RSS Feed

You are here

By: Kathy F. Mahdoubi

This year, Molecular Imaging Insight is not only providing some of the most stunning images from our pages, but also a few research exclusives and offerings from a handful of scientific meetings from around the world, including the Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), the World Molecular Imaging Congress (WMIC) and the European Congress of Radiology (ECR). These exemplary images cover the full spectrum of molecular imaging from brain SPECT to oncologic PET and hyperpolarized MRI.

 

Source: GE Healthcare

Amyloid PET Imaging Via Vizamyl

F-18 flutemetamol, also known as Vizamyl, is one of three FDA-approved amyloid PET agents to help rule out Alzheimer’s disease in the absence of amyloid...

Features
 - Alzheimer's
By: Kathy F. Mahdoubi
First came the discovery of beta-amyloid plaque as a precursor of cognitive decline, and then came the tangles of tau and wonderment in researchers’ minds as to their relationship.
Features
 - Colon
By: Evan Godt
As colorectal cancer screening research marches on and options for screening continue to be evaluated, one constant remains.
Conference News
 - South Korea
By: Kathy F. Mahdoubi
The 2014 World Molecular Imaging Congress (WMIC) put a spotlight on the basic science and translation of molecular imaging at the World Trade Center in Seoul, South Korea, in September.
Features
 - Radiation
By: Evan Godt
Follow-up on the largest randomized study of fractionation techniques for radiation treatment has shown that hyperfractionated radiotherapy improves local-regional control and overall survival at...
Features
 - Gut
By: Julie Ritzer Ross
Currently ranked the fourth-leading cause of cancer-related deaths in the U.S. and slated to move up the list to No. 2 in the next few years, pancreatic cancer has the highest mortality rate and...
Features
 - Busted brick wall
By: Claudette Lew
The evolution of SPECT imaging has taken many twists and turns as both equipment technology and new radiopharmaceuticals have been developed over the past decade.
Features
 - Light beams
By: Kathy F. Mahdoubi
Proton therapy used to be the next-generation cancer treatment that was larger than life and too expensive for any institution other than the most cutting-edge research hospital.
Editorial
 - Robert Atcher
By: Robert W. Atcher, Phd, MBA
During my term as president of the Society of Nuclear Medicine (And Molecular Imaging, now appended), we were in the midst of the Molecular Imaging Campaign that was successful in increasing the...
Features
 - Business Swim
By: Julie Ritzer Ross
As is true in all clinical disciplines, nuclear medicine practitioners face challenges and obstacles that do not end with procedures and patient care.